Iron removal during continuous ambulatory peritoneal dialysis using deferoxamine.
D000328:Adult; D000755:Anemia, Sickle Cell / Q000150:complications; D003676:Deferoxamine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007501:Iron / Q000378:metabolism*; D007676:Kidney Failure, Chronic / Q000150:complications*; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*
D007501:Iron; D003676:Deferoxamine